Knopp Neurosciences

Lung model
Biotech

Bain leads $350M bet on oral asthma startup to fund phase 3

The series A positions Areteia to run phase 3 trials of an asthma candidate designed to have biologiclike efficacy in an oral dosage form.
Nick Paul Taylor Jul 12, 2022 7:00am
Digital X-ray brain on blue background neurons

Biohaven to take a chance on BMS' once-failed DMD med

Feb 25, 2022 10:49am
Lung model

Knopp's oral asthma drug hits primary endpoint in phase 2

Jan 14, 2021 9:02am